DELAYED TREATMENT MODIFICATIONS FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WITH VERY POOR GLYCEMIC CONTROL

被引：0
|
作者：
Schwab, P. [1 ]
Saundankar, V [1 ]
Bouchard, J. R. [2 ]
Moretz, C. [1 ]
Baltz, J. [3 ]
机构：
[1] Comprehens Hlth Insights, Louisville, KY USA
[2] Novo Nordisk Inc, Princeton, NJ USA
[3] Humana Inc, Louisville, KY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.1540
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB153
引用
下载
收藏
页码：A264 / A264
页数：1
相关论文
共 50 条
  • [21] Real-World (RW) Glycemic Control and Medication Adherence among Patients with Type 2 Diabetes Mellitus (T2DM) Initiated on Canagliflozin
    Jain, Rahul
    Cai, Jennifer
    Fu, An-Chen
    Chow, Wing
    Tan, Hiangkiat
    DIABETES, 2016, 65 : A304 - A305
  • [22] EFFECTS OF A TELEMEDICAL SUPPORTED LIFESTYLE INTERVENTION TO IMPROVE GLYCEMIC CONTROL AND SELF-MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Dunkel, A.
    Wunderlich, M.
    Zank, S.
    Polidori, M. C.
    Woopen, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A190 - A190
  • [23] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [24] Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program
    Mahaffey, Kenneth W.
    Ianus, Juliana
    Damaraju, C. V.
    Neal, Bruce
    De Zeeuw, Dick
    Fulcher, Greg
    Pfeifer, Michael
    Matthews, David R.
    DIABETES, 2019, 68
  • [25] Characteristics of Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Therapy with Canagliflozin
    Martin, Silas C.
    Henk, Henry J.
    Chow, Wing
    DIABETES, 2014, 63 : A307 - A307
  • [26] MobiDiabet: Mobile Telemonitoring System for Patients with Type 2 Diabetes Mellitus (T2DM)
    Alcala Juarez, Anakaren
    Hernandez Villegas, Manuel Alejandro
    Dominguez, Eduardo Lopez
    Hernandez Velazquez, Yesenia
    Dominguez Isidro, Saul
    Ovando Diego, Liliana
    Hernandez Sanchez, Olivia
    De La Calleja, Jorge
    Pomares Hernandez, Saul Eduardo
    Medina Nieto, Maria Auxilio
    APPLIED SCIENCES-BASEL, 2020, 10 (22): : 1 - 36
  • [27] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Thulasi, Arun
    Kumar, Vinod
    Jagannathan, Aarti
    Angadi, Praveen
    Umamaheswar, Kundapur
    Raghuram, Nagarathna
    JOURNAL OF RELIGION & HEALTH, 2022, 61 (03): : 1951 - 1965
  • [28] Development and Validation of Yoga Program for Patients with Type 2 Diabetes Mellitus (T2DM)
    Arun Thulasi
    Vinod Kumar
    Aarti Jagannathan
    Praveen Angadi
    Kundapur Umamaheswar
    Nagarathna Raghuram
    Journal of Religion and Health, 2022, 61 : 1951 - 1965
  • [29] Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI)
    Barnett, Anthony H.
    Mithal, Ambrish
    Manassie, Jenny
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A286 - A286
  • [30] Achievement of Diabetes-related Treatment Goals with Canagliflozin (CANA) in Patients with Type 2 Diabetes Mellitus (T2DM)
    Blonde, Lawrence
    Woo, Vincent
    Mathieu, Chantal
    Yee, Jacqueline
    Vijapurkar, Ujjwala
    Meininger, Gary
    DIABETES, 2014, 63 : A284 - A284
12345